Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria | 49 | 2023 | 1227 | 8.250 |
Why?
|
Nigeria | 75 | 2024 | 770 | 5.270 |
Why?
|
Antimalarials | 32 | 2022 | 907 | 4.940 |
Why?
|
Artemisinins | 15 | 2020 | 218 | 2.120 |
Why?
|
Diagnostic Tests, Routine | 15 | 2022 | 787 | 1.790 |
Why?
|
Pregnancy Complications, Parasitic | 5 | 2022 | 61 | 1.510 |
Why?
|
Health Knowledge, Attitudes, Practice | 15 | 2024 | 4016 | 1.440 |
Why?
|
Rural Population | 13 | 2021 | 2285 | 1.130 |
Why?
|
Health Personnel | 12 | 2022 | 3335 | 1.090 |
Why?
|
Prenatal Care | 7 | 2022 | 1139 | 0.900 |
Why?
|
Parasitemia | 6 | 2022 | 165 | 0.880 |
Why?
|
Mothers | 7 | 2021 | 2198 | 0.820 |
Why?
|
Urban Population | 4 | 2020 | 2036 | 0.810 |
Why?
|
Fever | 9 | 2022 | 1618 | 0.800 |
Why?
|
Operations Research | 2 | 2018 | 22 | 0.770 |
Why?
|
Health Education | 5 | 2011 | 1052 | 0.760 |
Why?
|
Cross-Sectional Studies | 38 | 2024 | 26127 | 0.750 |
Why?
|
Drug Combinations | 8 | 2020 | 2048 | 0.750 |
Why?
|
Laboratories, Hospital | 1 | 2022 | 192 | 0.710 |
Why?
|
Hypertension | 6 | 2024 | 8540 | 0.700 |
Why?
|
Insecticide-Treated Bednets | 5 | 2022 | 68 | 0.690 |
Why?
|
Ethanolamines | 3 | 2008 | 153 | 0.670 |
Why?
|
Prediabetic State | 2 | 2023 | 545 | 0.660 |
Why?
|
Nonprescription Drugs | 1 | 2020 | 118 | 0.660 |
Why?
|
Fluorenes | 3 | 2008 | 157 | 0.640 |
Why?
|
Needs Assessment | 3 | 2021 | 1139 | 0.630 |
Why?
|
Pharmacies | 1 | 2020 | 169 | 0.610 |
Why?
|
Home Nursing | 2 | 2008 | 92 | 0.600 |
Why?
|
Dental Health Surveys | 1 | 2017 | 39 | 0.600 |
Why?
|
Communicable Disease Control | 3 | 2021 | 846 | 0.590 |
Why?
|
Case Management | 6 | 2021 | 272 | 0.590 |
Why?
|
Amodiaquine | 4 | 2019 | 58 | 0.590 |
Why?
|
Tooth Diseases | 1 | 2017 | 74 | 0.580 |
Why?
|
Transients and Migrants | 1 | 2020 | 165 | 0.580 |
Why?
|
Laboratories | 3 | 2019 | 458 | 0.560 |
Why?
|
Perception | 2 | 2021 | 1197 | 0.550 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2022 | 832 | 0.490 |
Why?
|
Patient Acceptance of Health Care | 5 | 2020 | 3205 | 0.480 |
Why?
|
Uganda | 12 | 2024 | 1332 | 0.480 |
Why?
|
Clinical Protocols | 1 | 2020 | 1440 | 0.460 |
Why?
|
Caregivers | 8 | 2020 | 2238 | 0.450 |
Why?
|
Epidemics | 1 | 2019 | 512 | 0.430 |
Why?
|
Sulfadoxine | 3 | 2019 | 46 | 0.420 |
Why?
|
Preventive Health Services | 1 | 2017 | 567 | 0.420 |
Why?
|
Primary Prevention | 1 | 2020 | 1186 | 0.410 |
Why?
|
Adult | 54 | 2024 | 221203 | 0.410 |
Why?
|
Pyrimethamine | 3 | 2019 | 94 | 0.410 |
Why?
|
Life Style | 1 | 2024 | 3917 | 0.410 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1156 | 0.400 |
Why?
|
Oral Health | 1 | 2017 | 492 | 0.400 |
Why?
|
Female | 71 | 2024 | 392686 | 0.360 |
Why?
|
Patients | 1 | 2017 | 907 | 0.360 |
Why?
|
Burkina Faso | 7 | 2016 | 86 | 0.340 |
Why?
|
Health Services Research | 4 | 2021 | 1812 | 0.340 |
Why?
|
Medication Adherence | 2 | 2019 | 2176 | 0.330 |
Why?
|
Research Design | 2 | 2023 | 6180 | 0.330 |
Why?
|
Humans | 91 | 2024 | 761572 | 0.330 |
Why?
|
Health Facilities | 6 | 2020 | 580 | 0.320 |
Why?
|
Research | 1 | 2017 | 1982 | 0.320 |
Why?
|
Young Adult | 30 | 2024 | 59255 | 0.320 |
Why?
|
Child, Preschool | 23 | 2023 | 42230 | 0.320 |
Why?
|
Male | 56 | 2024 | 360842 | 0.310 |
Why?
|
Breast Diseases | 2 | 2024 | 442 | 0.300 |
Why?
|
Audiovisual Aids | 1 | 2008 | 99 | 0.300 |
Why?
|
Prevalence | 12 | 2023 | 15732 | 0.300 |
Why?
|
Middle Aged | 37 | 2024 | 220920 | 0.290 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5336 | 0.280 |
Why?
|
Community-Based Participatory Research | 1 | 2008 | 221 | 0.270 |
Why?
|
Residence Characteristics | 1 | 2016 | 2094 | 0.270 |
Why?
|
Appointments and Schedules | 2 | 2019 | 443 | 0.270 |
Why?
|
Immunization Programs | 2 | 2021 | 268 | 0.270 |
Why?
|
Drug Prescriptions | 4 | 2020 | 1670 | 0.260 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7391 | 0.250 |
Why?
|
Africa South of the Sahara | 7 | 2020 | 744 | 0.240 |
Why?
|
Infant | 17 | 2023 | 36192 | 0.240 |
Why?
|
Program Development | 3 | 2021 | 1297 | 0.240 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2472 | 0.240 |
Why?
|
Echinococcus granulosus | 1 | 2023 | 11 | 0.230 |
Why?
|
Laboratory Personnel | 2 | 2022 | 19 | 0.230 |
Why?
|
Echinococcosis | 1 | 2023 | 31 | 0.230 |
Why?
|
Mosquito Control | 3 | 2022 | 106 | 0.220 |
Why?
|
Local Government | 2 | 2021 | 81 | 0.220 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2016 | 2151 | 0.210 |
Why?
|
Chloroquine | 4 | 2008 | 274 | 0.210 |
Why?
|
Microbiological Techniques | 2 | 2020 | 97 | 0.200 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 6312 | 0.200 |
Why?
|
Microscopy | 4 | 2018 | 903 | 0.200 |
Why?
|
Malaria, Falciparum | 2 | 2023 | 1077 | 0.200 |
Why?
|
Sputum | 2 | 2022 | 506 | 0.200 |
Why?
|
Socioeconomic Factors | 7 | 2020 | 7827 | 0.190 |
Why?
|
Program Evaluation | 2 | 2021 | 2495 | 0.190 |
Why?
|
Tetanus Toxoid | 1 | 2021 | 189 | 0.190 |
Why?
|
Pregnancy | 12 | 2022 | 29876 | 0.190 |
Why?
|
Guideline Adherence | 3 | 2020 | 2220 | 0.180 |
Why?
|
Patient Compliance | 5 | 2019 | 2690 | 0.180 |
Why?
|
Epidemiology | 2 | 2014 | 279 | 0.180 |
Why?
|
Cities | 1 | 2023 | 546 | 0.180 |
Why?
|
Focus Groups | 5 | 2019 | 1413 | 0.180 |
Why?
|
HIV Infections | 3 | 2022 | 17352 | 0.180 |
Why?
|
Overweight | 3 | 2022 | 2417 | 0.180 |
Why?
|
Logistic Models | 7 | 2019 | 13255 | 0.170 |
Why?
|
Ambulatory Care Facilities | 2 | 2019 | 935 | 0.170 |
Why?
|
Child | 15 | 2023 | 80156 | 0.170 |
Why?
|
Employee Performance Appraisal | 1 | 2020 | 86 | 0.170 |
Why?
|
Immunization | 2 | 2021 | 1227 | 0.170 |
Why?
|
Attitude to Health | 1 | 2008 | 2025 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12148 | 0.160 |
Why?
|
Alcohol Drinking | 2 | 2024 | 4028 | 0.150 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 239 | 0.150 |
Why?
|
DMF Index | 1 | 2017 | 87 | 0.150 |
Why?
|
Case-Control Studies | 5 | 2024 | 22176 | 0.150 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 291 | 0.150 |
Why?
|
Tanzania | 3 | 2016 | 1387 | 0.150 |
Why?
|
Democratic Republic of the Congo | 1 | 2017 | 86 | 0.150 |
Why?
|
Public Health | 3 | 2017 | 2669 | 0.140 |
Why?
|
Inservice Training | 1 | 2020 | 375 | 0.140 |
Why?
|
Capacity Building | 1 | 2020 | 258 | 0.140 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4853 | 0.140 |
Why?
|
Knowledge | 1 | 2018 | 177 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Personal Satisfaction | 1 | 2021 | 644 | 0.140 |
Why?
|
Obesity | 3 | 2023 | 12947 | 0.140 |
Why?
|
Accidents | 1 | 2017 | 165 | 0.140 |
Why?
|
Heart Failure | 1 | 2021 | 11670 | 0.130 |
Why?
|
Postnatal Care | 1 | 2019 | 262 | 0.130 |
Why?
|
Twins | 1 | 2018 | 339 | 0.130 |
Why?
|
Age Distribution | 3 | 2017 | 2880 | 0.130 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 211 | 0.130 |
Why?
|
Fast Foods | 1 | 2018 | 211 | 0.130 |
Why?
|
Reminder Systems | 1 | 2019 | 388 | 0.130 |
Why?
|
Adolescent | 15 | 2022 | 88324 | 0.120 |
Why?
|
Rural Health Services | 2 | 2009 | 384 | 0.120 |
Why?
|
Urbanization | 1 | 2015 | 100 | 0.120 |
Why?
|
Risk Factors | 13 | 2024 | 74213 | 0.120 |
Why?
|
Qualitative Research | 2 | 2020 | 3023 | 0.120 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 983 | 0.120 |
Why?
|
Poultry | 1 | 2014 | 80 | 0.120 |
Why?
|
Outpatients | 1 | 2002 | 1597 | 0.110 |
Why?
|
South Africa | 2 | 2016 | 1843 | 0.110 |
Why?
|
Influenza in Birds | 1 | 2014 | 76 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 746 | 0.110 |
Why?
|
Blood Pressure | 2 | 2022 | 8481 | 0.110 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2014 | 113 | 0.110 |
Why?
|
Occupations | 1 | 2015 | 515 | 0.110 |
Why?
|
Maternal Health Services | 1 | 2019 | 461 | 0.110 |
Why?
|
Diet | 2 | 2024 | 8075 | 0.110 |
Why?
|
Administration, Rectal | 3 | 2016 | 70 | 0.110 |
Why?
|
Disease Outbreaks | 2 | 2020 | 1749 | 0.110 |
Why?
|
Counseling | 1 | 2020 | 1547 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 675 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2020 | 26198 | 0.100 |
Why?
|
Violence | 1 | 2017 | 936 | 0.090 |
Why?
|
Administration, Oral | 2 | 2016 | 4021 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1914 | 0.090 |
Why?
|
Disease Transmission, Infectious | 1 | 2016 | 560 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3156 | 0.090 |
Why?
|
Antitubercular Agents | 1 | 2019 | 1375 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1813 | 0.080 |
Why?
|
Refugees | 1 | 2017 | 596 | 0.080 |
Why?
|
Commerce | 1 | 2014 | 606 | 0.080 |
Why?
|
Directly Observed Therapy | 2 | 2019 | 139 | 0.080 |
Why?
|
Community Medicine | 1 | 2008 | 23 | 0.080 |
Why?
|
Awareness | 1 | 2013 | 648 | 0.080 |
Why?
|
Chemoprevention | 1 | 2011 | 326 | 0.080 |
Why?
|
Interviews as Topic | 3 | 2014 | 2696 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2585 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3889 | 0.070 |
Why?
|
Vaccines | 1 | 2016 | 844 | 0.070 |
Why?
|
Insurance, Health | 1 | 2020 | 2498 | 0.070 |
Why?
|
Morphine | 1 | 2012 | 657 | 0.070 |
Why?
|
Health Expenditures | 1 | 2020 | 2366 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2023 | 14666 | 0.070 |
Why?
|
Educational Status | 2 | 2017 | 2522 | 0.070 |
Why?
|
Family Characteristics | 3 | 2018 | 1004 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15501 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2008 | 5247 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 39970 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2016 | 3600 | 0.070 |
Why?
|
Ghana | 1 | 2008 | 315 | 0.070 |
Why?
|
Selection, Genetic | 2 | 2007 | 868 | 0.070 |
Why?
|
Child Development | 1 | 2018 | 2306 | 0.070 |
Why?
|
Hospitals | 1 | 2019 | 3882 | 0.070 |
Why?
|
Government Programs | 1 | 2008 | 279 | 0.070 |
Why?
|
Blood | 1 | 2008 | 596 | 0.060 |
Why?
|
Tuberculosis | 1 | 2019 | 2017 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2018 | 3188 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5890 | 0.060 |
Why?
|
Aged | 8 | 2024 | 169310 | 0.060 |
Why?
|
Geography | 3 | 2014 | 656 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2491 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2020 | 3416 | 0.060 |
Why?
|
Interview, Psychological | 1 | 2008 | 809 | 0.060 |
Why?
|
Haplotypes | 2 | 2007 | 2713 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2018 | 2947 | 0.060 |
Why?
|
HIV-1 | 1 | 2022 | 6863 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5428 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3384 | 0.060 |
Why?
|
Cameroon | 1 | 2024 | 76 | 0.060 |
Why?
|
Antibodies, Helminth | 1 | 2023 | 57 | 0.060 |
Why?
|
Health Services Accessibility | 4 | 2020 | 5440 | 0.060 |
Why?
|
Body Mass Index | 2 | 2023 | 12954 | 0.060 |
Why?
|
Cultural Characteristics | 1 | 2005 | 251 | 0.050 |
Why?
|
Health Surveys | 3 | 2019 | 4061 | 0.050 |
Why?
|
Pilot Projects | 3 | 2017 | 8633 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2023 | 397 | 0.050 |
Why?
|
Mammography | 1 | 2013 | 2430 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2024 | 21017 | 0.050 |
Why?
|
Proteins | 1 | 2016 | 6032 | 0.050 |
Why?
|
Developing Countries | 3 | 2020 | 2885 | 0.050 |
Why?
|
Universal Precautions | 1 | 2020 | 34 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 374 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9319 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2002 | 395 | 0.040 |
Why?
|
Needlestick Injuries | 1 | 2020 | 71 | 0.040 |
Why?
|
Disease Notification | 1 | 2020 | 95 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6075 | 0.040 |
Why?
|
Dogs | 1 | 2023 | 3839 | 0.040 |
Why?
|
Primary Health Care | 2 | 2019 | 4686 | 0.040 |
Why?
|
Cohort Studies | 3 | 2023 | 41493 | 0.040 |
Why?
|
Palpation | 1 | 2018 | 166 | 0.040 |
Why?
|
Body Fluids | 1 | 2020 | 320 | 0.040 |
Why?
|
Palliative Care | 1 | 2013 | 3598 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5293 | 0.040 |
Why?
|
Contact Tracing | 1 | 2020 | 271 | 0.040 |
Why?
|
Pregnancy Trimesters | 1 | 2019 | 197 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5841 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39107 | 0.040 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2016 | 25 | 0.030 |
Why?
|
Ethiopia | 1 | 2019 | 464 | 0.030 |
Why?
|
Pain | 1 | 2012 | 5073 | 0.030 |
Why?
|
Ultrasonography, Mammary | 1 | 2018 | 239 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2002 | 2927 | 0.030 |
Why?
|
Estradiol | 1 | 2023 | 1937 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2016 | 80 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2018 | 583 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 957 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 3808 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2022 | 2707 | 0.030 |
Why?
|
Prehypertension | 1 | 2015 | 63 | 0.030 |
Why?
|
Education, Veterinary | 1 | 2014 | 7 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 267 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 64684 | 0.030 |
Why?
|
Rural Health | 1 | 2016 | 296 | 0.030 |
Why?
|
Genome, Human | 1 | 2007 | 4425 | 0.030 |
Why?
|
Postmenopause | 1 | 2023 | 2513 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2014 | 121 | 0.030 |
Why?
|
Government Agencies | 1 | 2014 | 160 | 0.030 |
Why?
|
Population Surveillance | 2 | 2014 | 2598 | 0.030 |
Why?
|
Plasmodium falciparum | 1 | 2023 | 1742 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 532 | 0.030 |
Why?
|
Breast Self-Examination | 1 | 2013 | 33 | 0.030 |
Why?
|
Private Sector | 1 | 2016 | 398 | 0.030 |
Why?
|
Education, Professional | 1 | 2013 | 52 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1351 | 0.030 |
Why?
|
Communications Media | 1 | 2013 | 42 | 0.030 |
Why?
|
Community Networks | 1 | 2014 | 201 | 0.030 |
Why?
|
Physical Examination | 1 | 2018 | 1255 | 0.030 |
Why?
|
Students | 1 | 2022 | 1741 | 0.030 |
Why?
|
Drug Resistance | 1 | 2018 | 1596 | 0.030 |
Why?
|
Postpartum Period | 1 | 2018 | 1173 | 0.020 |
Why?
|
Pregnant Women | 1 | 2016 | 566 | 0.020 |
Why?
|
Health Priorities | 1 | 2014 | 374 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2007 | 15936 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2199 | 0.020 |
Why?
|
Africa | 1 | 2013 | 709 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15266 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2281 | 0.020 |
Why?
|
Animals | 4 | 2023 | 168467 | 0.020 |
Why?
|
Specimen Handling | 1 | 2014 | 702 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3461 | 0.020 |
Why?
|
Breast | 1 | 2018 | 1967 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 803 | 0.020 |
Why?
|
Goals | 1 | 2014 | 711 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 80646 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1170 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1422 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3801 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54426 | 0.020 |
Why?
|
Motivation | 1 | 2016 | 2006 | 0.020 |
Why?
|
Antiporters | 1 | 2007 | 277 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9646 | 0.020 |
Why?
|
Nurses | 1 | 2015 | 2478 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15843 | 0.010 |
Why?
|
Self Administration | 1 | 2005 | 390 | 0.010 |
Why?
|
Health Behavior | 1 | 2015 | 2644 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7407 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2007 | 1519 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22173 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1776 | 0.010 |
Why?
|
Genetics, Population | 1 | 2007 | 937 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2007 | 1998 | 0.010 |
Why?
|
Family | 1 | 2013 | 3194 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14607 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18398 | 0.010 |
Why?
|
Fathers | 1 | 2005 | 376 | 0.010 |
Why?
|
Communication Barriers | 1 | 2005 | 413 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3551 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3683 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10212 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 3250 | 0.010 |
Why?
|
Health Promotion | 1 | 2013 | 2214 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3792 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3606 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20099 | 0.010 |
Why?
|
Causality | 1 | 2005 | 1242 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5439 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2013 | 58986 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3322 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17904 | 0.010 |
Why?
|
United States | 1 | 2014 | 72335 | 0.000 |
Why?
|
Concepts
(311)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_